2m 2m 2m 2m 2m 2m 2m
DENALI THERAPTCS (DNLI)
NASDAQ
$24.77+$0.72 (+3.01%)
Price as of Jun 23, 2026 6:24 PM EDT- $3.8BMarket Cap
- 76.58%1-Year Change
- BiotechnologyIndustry
DENALI THERAPTCS (DNLI)
$24.77+$0.72 (+3.01%)
DNLI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.05 | ||
Change | +$0.74 (+3.17%) | ||
Open | $23.90 | ||
High | $24.34 | ||
Low | $23.64 | ||
Previous Close | $23.31 | ||
Volume | 1,612,585 | ||
30-Day Average Volume | 1,874,666 | ||
1-Week Change | 8.24% | ||
1-Month Change | 29.02% | ||
1-Year Change | 76.58% | ||
3-Year Change | -21.56% | ||
5-Year Change | -65.22% | ||
Fundamentals | |||
Shares Outstanding | 158.7M | ||
Total Assets | $1.3B | ||
Market Cap | $3.8B | ||
Enterprise Value | $3.4B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$128.4M | ||
Free Cash Flow | -$133.7M | ||
EBIT | -$128.4M | ||
EBITDA | -$125.6M | ||
Net Working Capital | $912.6M | ||
EPS | -$0.69 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -35 | ||
PEG | -6 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue